Janux Therapeutics, Inc. (JANX) Tops Q4 EPS by 11c
Tweet
Share
E-mailGet Alerts JANX Hot Sheet
Join SI Premium – FREE
Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q4 EPS of ($0.51), $0.11 better than the analyst estimate of ($0.62).
For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Pacific Booker Minerals Inc. Adopts Advance Notice Policy for Director Elections
- Worthington Industries (WOR) Misses Q4 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
